Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data.
Ashna TalwarSatabdi ChatterjeeSusan AbughoshMichael JohnsonJeffrey ShererRajender R AparasuPublished in: Pharmacotherapy (2024)
This study found the burden of deliriogenic medications over the 1-year follow-up showed increasing trends in older adults with AD, even though there was some level shift in CAB and sedative load after the delirium event.